We are pleased to share a new application of our preclinical model on Oesophageal Epithelium developed to assess the film forming properties of formulations intended to act in an acidic micro-environment mimicking gastric fluid refluxate.
Heartburn is the most frequent typical symptom of gastro-oesophageal reflux disease (GERD) and is experienced by 14% of the global population.
The article confirms the interest of pharmaceutical industry for GERD treatments and the relevance of 3D reconstructed tissues in the definition of the mechanism of action.